LGR4 and hepatocellular carcinoma: Functionally and mechanistically, Circ_0003945 might directly target miR‐34c‐5p to release its inhibition of LGR4 expression, finally activating the β‐catenin pathway, and thus, enhancing malignant properties of HCC cell.